Liquid Dosage

Monoclonal Antibodies

GEA is a leading specialist in the field of process equipment for liquid processing and metering for the pharmaceutical and biotech industries, including fermentation plant for the manufacture of products such as monoclonal antibodies (mAbs) for diagnostic and therapeutic purposes.

Downloads

GEA Insights

Cows in a pasture

Healthy hooves, healthier cows

Dairy farms rely on a simple but critical foundation: healthy hooves. When that foundation weakens, performance, welfare and efficiency quickly follow – regardless of how advanced the dairy operation may be.

Opening of the new GEA Pharma Technology Center in Elsdorf: Johannes Giloth (COO, GEA), Michael Asenkerschbaumer (Managing Director Lyophilization), Andreas Heller (Mayor of Elsdorf), Prof. Dieter Kempf (Chairman of the Supervisory Board, GEA), Mona Neubaur (Minister of Economic Affairs of North Rhine-Westphalia) and GEA CEO Stefan Klebert (front row, from left to right). (Photo: GEA)

GEA opens new technology center, strengthening its position in the growing pharmaceutical applications market

Together with Mona Neubaur, Minister of Economic Affairs of the German state of North Rhine-Westphalia, GEA CEO Stefan Klebert has opened a new technology center for pharmaceutical freeze-drying systems in Elsdorf, Germany. GEA employs approximately 260 people at the facility, which combines research and development with production and service under one roof.

Children drinking water

Turning wastewater into value

GEA centrifuges enable wastewater reuse, resource recovery, and water security by turning biosolids into value in a world facing growing water scarcity.

Receive news from GEA

Stay in touch with GEA innovations and stories by signing up for news from GEA.

Need assistance?

We are here to help! With just a few details we will be able to respond to your inquiry.